Iatrogenic Cushing Syndrome Following Lumbar Medial Branch Block in a Patient with HIV on Ritonavir and Darunavir

References

• Hoy D , MarchL , WoolfAet al. The global burden of neck pain: estimates from the global burden of disease 2010 study. Ann. Rheum. Dis.73(7), 1309–1315 (2014).
   PubMed Web of Science ®Google Scholar
• Urits I , BurshteinA , SharmaMet al. Low back pain, a comprehensive review: pathophysiology, diagnosis, and treatment. Curr. Pain Headache Rep.23(3), 23 (2019).
   PubMed Web of Science ®Google Scholar
• Habib GS . Systemic effects of intra-articular corticosteroids. Clin. Rheumatol.28(7), 749–756 (2009).
   PubMed Web of Science ®Google Scholar
• Teeraananchai S , KerrSJ , AminJ , RuxrungthamK , LawMG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med.18(4), 256–266 (2017).
   PubMed Web of Science ®Google Scholar
• Tseng A , HughesCA , WuJ , SeetJ , PhillipsEJ. Cobicistat versus ritonavir: similar pharmacokinetic enhancers but some important differences. Ann. Pharmacother.51(11), 1008–1022 (2017).
   PubMed Web of Science ®Google Scholar
• Sabin CA , HardingR , BagkerisEet al. The predictors of pain extent in people living with HIV. AIDS34(14), 2071–2079 (2020).
   PubMed Web of Science ®Google Scholar
• Wassner C , MaitiS , KodroffK , CohenH. Iatrogenic adrenal insufficiency secondary to combination therapy with elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and interlaminar triamcinolone injection in an AIDS patient. J. Int. Assoc. Provid. AIDS Care16(6), 535–539 (2017).
   PubMedGoogle Scholar
• Yombi JC , MaiterD , BelkhirL , NzeusseuA , VandercamB. Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin. Rheumatol.27(Suppl. 2), S79–S82 (2008).
   PubMedGoogle Scholar
• Nieman LK , BillerBMK , FindlingJWet al. The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab.29(3), 103–106 (2008).
   Google Scholar
• Nieman LK . Diagnosis of cushing’s syndrome in the modern era. Endocrinol. Metab. Clin. North Am.47(2), 259–273 (2018).
   PubMed Web of Science ®Google Scholar
• Schwarze-Zander C , KlingmüllerD , KlümperJ , StrassburgCP , RockstrohJK. Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature. Infection41(6), 1183–1187 (2013).
   PubMed Web of Science ®Google Scholar
• Grierson MJ , HarrastMA. Iatrogenic cushing syndrome after epidural steroid injections for lumbar radiculopathy in an HIV-infected patient treated with ritonavir: a case report highlighting drug interactions for spine interventionalists. PMR4(3), 234–237 (2012).
   PubMedGoogle Scholar
• Dort K , PadiaS , WispelweyB , MooreCC. Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report. AIDS Res. Ther.6, 10 (2009).
   PubMedGoogle Scholar
• Ramanathan R , PauAK , BusseKHet al. Iatrogenic cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin. Infect. Dis.47(12), e97–99 (2008).
   PubMed Web of Science ®Google Scholar
• Makaram N , RussellCD , RobertsSB , StevensJ , MacPhersonG. Exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug–drug interaction between cobicistat and intrabursal triamcinolone. BMJ Case Rep.11(1), e226912 (2018).
   PubMedGoogle Scholar
• Villikka K , VarisT , BackmanJT , NeuvonenPJ , KivistöKT. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo. Cancer Chemother. Pharmacol. Suppl.57(6–7), 457–460 (2002).
   Google Scholar
• Friedly JL , ComstockBA , HeagertyPJet al. Systemic effects of epidural steroid injections for spinal stenosis. Pain159(5), 876–883 (2018).
   PubMed Web of Science ®Google Scholar
• Foisy MM , YakiwchukEMK , ChiuI , SinghAE. Adrenal suppression and Cushing’s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med.9(6), 389–396 (2008).
   PubMed Web of Science ®Google Scholar
• Frankel JK , PackerCD. Cushing’s syndrome due to antiretroviral–budesonide interaction. Ann. Pharmacother.45(6), 823–824 (2011).
   PubMed Web of Science ®Google Scholar
• Yeoh SW . Iatrogenic cushing syndrome from interaction between ritonavir and oral budesonide during direct acting antiviral hepatitis C therapy. J. Clin. Exp. Hepatol.6(3), 246–249 (2016).
   PubMedGoogle Scholar
• Penzak SR , FormentiniE , AlfaroRM , LongM , NatarajanV , KovacsJ. Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers. J. Acquir. Immune Defic. Syndr.40(5), 573–580
   PubMed Web of Science ®Google Scholar
• Matoulková P , PávekP , MalýJ , VlčekJ. Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction. Expert Opin. Drug Metab. Toxicol.10(3), 425–435 (2014).
   PubMed Web of Science ®Google Scholar
• Busse KH , FormentiniE , AlfaroRM , KovacsJA , PenzakSR. Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals. J. Acquir. Immune Defic. Syndr.48(5), 561–566 (2008).
   PubMed Web of Science ®Google Scholar
• Gupta SK , DubéMP. Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy. Clin. Infect. Dis.35(6), e69–71 (2002).
   PubMed Web of Science ®Google Scholar
• Sadarangani S , BergML , MauckW , RizzaS. Iatrogenic Cushing syndrome secondary to ritonavir–epidural triamcinolone interaction: an illustrative case and review. Interdiscip. Perspect. Infect. Dis.2014, 849432 (2014).
   PubMedGoogle Scholar
• Lavin PJ , WorkmanR. Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids. Headache J. Head Face Pain41(9), 902–904 (2001).
   PubMed Web of Science ®Google Scholar